Introduction:
Despite improvements in the management of ischemic stroke (IS), survivors continue to face high risk of recurrent events, including IS, major adverse vascular events (MAVE), and bleeding. Long-term real-world evidence is needed to characterize the burden of recurrent events under current secondary stro...
Meghan Thompson, J. Banefelt, A. Beaudet et al.· Circulation· 0 citations
Patients diagnosed with atrial fibrillation (AF) are at risk of clinically meaningful ischaemic and haemorrhagic events, and death. Contemporary data are essential to define residual risk in the real-world setting and to help identify the current unmet need.
To describe the occurrence and cumulative incide...
K. Smith, P. Sandin, A. Beaudet et al.· European Heart Journal· 0 citations
In contemporary OAC-treated AF populations, the occurrence of thrombotic or bleeding events was associated with a marked increase in the risk of recurrent events and all-cause mortality.
A. Kang, E. O'Brien, Achim Wolf et al.· Circulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.